SCHEMBL21579232

SCHEMBL21579232

c1ccc2c(c1)cc(-c1c3ccccc3c(-c3ccc(-c4ccc5cc(-c6c7ccccc7c(-c7cccc8oc9ccccc9c78)c7ccccc67)ccc5c4)c4oc5ccccc5c34)c3ccccc13)c1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.40
▸ GPR84 Q9NQS5 3/20 0.38
▸ PRKDC P78527 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HIF1A Q16665 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CDC14B O60729 2/20 0.34
▸ CDC14A Q9UNH5 2/20 0.34
▸ SOS1 Q07889 2/20 0.32
▸ MIF P14174 1/20 0.32
▸ GGPS1 O95749 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22855101 0.90 ALOX5 (0.40) ALOX5GPR84PRKDCL3MBTL1TSHR
SCHEMBL22088904 0.89 ALOX5 (0.37) ALOX5GPR84PRKDCALDH1A1CDC14B
SCHEMBL23504719 0.89 SOS1 (0.38) ALOX5GPR84PRKDCL3MBTL1TSHR
SCHEMBL18382853 0.89 GPR84 (0.41) ALOX5GPR84L3MBTL1TSHRHIF1A
SCHEMBL18382863 0.89 ALOX5 (0.39) ALOX5GPR84PRKDCL3MBTL1TSHR
SCHEMBL18382869 0.88 GPR84 (0.41) ALOX5GPR84PRKDCL3MBTL1TSHR
SCHEMBL22178611 0.88 CDC14B (0.36) ALOX5GPR84PRKDCALDH1A1HPGD
SCHEMBL22088897 0.88 ALOX5 (0.41) ALOX5GPR84PRKDCCDC14BCDC14A
SCHEMBL23504702 0.87 SOS1 (0.39) ALOX5GPR84PRKDCL3MBTL1TSHR
SCHEMBL23504636 0.87 HPGD (0.43) ALOX5GPR84PRKDCL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 — — US disclosed
US-11342512-B2 Compounds for organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2022-05-24 — — US disclosed
US-20220020925-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-01-20 — — US disclosed
US-10680181-B2 Organic electroluminescence device and novel compound IDEMITSU KOSAN CO., LTD. (JP) 2020-06-09 — — US disclosed
US-20190355914-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2019-11-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10680181-B2 Organic electroluminescence device and novel compound PIEZO1, TMEM109, OXA1L ALOX5 4031/4885GPR84 3941/4885PRKDC 3743/4885
US-11342512-B2 Compounds for organic electroluminescence device RPS19, RPL19, RPL18 ALOX5 3525/4885GPR84 3111/4885PRKDC 4812/4885
US-20190355914-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND PIEZO1, TMEM109, OXA1L ALOX5 4031/4885GPR84 3941/4885PRKDC 3743/4885
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 ALOX5 2721/4885GPR84 3183/4885PRKDC 3244/4885
US-20220020925-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE RPS19, RPL18, RPL19 ALOX5 3568/4885GPR84 2432/4885PRKDC 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback